|
US5023A
(en)
*
|
|
1847-03-20 |
|
Stocking-loom |
|
GB1562244A
(en)
|
1976-11-11 |
1980-03-05 |
Lock P M |
Wound dressing materials
|
|
GB1594389A
(en)
|
1977-06-03 |
1981-07-30 |
Max Planck Gesellschaft |
Dressing material for wounds
|
|
GB8516081D0
(en)
|
1985-06-25 |
1985-07-31 |
Ciba Geigy Ag |
Assay & purification of amyloid components
|
|
US6071517A
(en)
|
1986-07-07 |
2000-06-06 |
Medarex, Inc. |
Bispecific heteroantibodies with dual effector functions
|
|
DE3853219T2
(de)
|
1987-11-20 |
1995-06-29 |
Kanegafuchi Chemical Ind |
Methode zur Entfernung von Serum-Amyloid-Protein.
|
|
US7070994B2
(en)
|
1988-03-21 |
2006-07-04 |
Oxford Biomedica (Uk) Ltd. |
Packaging cells
|
|
US5272258A
(en)
|
1989-06-29 |
1993-12-21 |
Rush-Presbyterian-St. Luke's Medical Center |
Monoclonal antibodies to C-reactive protein
|
|
US5092876A
(en)
|
1989-08-30 |
1992-03-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cell attachment peptides derived from amyloid P component
|
|
WO1992021364A1
(en)
|
1991-05-31 |
1992-12-10 |
New England Deaconess Hospital Corporation |
Cea-binding proteins and methods for their isolation and use
|
|
US5591709A
(en)
|
1991-08-30 |
1997-01-07 |
Life Medical Sciences, Inc. |
Compositions and methods for treating wounds
|
|
US6054121A
(en)
|
1993-02-26 |
2000-04-25 |
The Picower Institute For Medical Research |
Modulation of immune responses in blood-borne mesenchymal cells
|
|
US5654186A
(en)
|
1993-02-26 |
1997-08-05 |
The Picower Institute For Medical Research |
Blood-borne mesenchymal cells
|
|
US5804446A
(en)
|
1993-02-26 |
1998-09-08 |
The Picower Institute For Medical Research |
Blood-borne mesenchymal cells
|
|
WO1994027640A1
(en)
|
1993-05-27 |
1994-12-08 |
The Regents Of The University Of Michigan |
Method of treatment and prevention of immune complex-induced lung injury
|
|
US5698589A
(en)
|
1993-06-01 |
1997-12-16 |
International Medical Innovations, Inc. |
Water-based topical cream containing nitroglycerin and method of preparation and use thereof
|
|
GB9317120D0
(en)
|
1993-08-17 |
1993-09-29 |
Royal Postgrad Med School |
Human serum amyloid p component
|
|
US5981470A
(en)
|
1994-06-07 |
1999-11-09 |
The University Of Birmingham |
Uterine fibroid treatment
|
|
US5989811A
(en)
|
1994-09-29 |
1999-11-23 |
Urocor, Inc. |
Sextant core biopsy predictive mechanism for non-organ confined disease status
|
|
US5750345A
(en)
|
1995-10-31 |
1998-05-12 |
Evanston Hospital Corporation |
Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
|
|
ATE226829T1
(de)
|
1996-01-25 |
2002-11-15 |
Profylakse Aps |
Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten
|
|
US6365570B1
(en)
|
1997-10-10 |
2002-04-02 |
Universiteit Utrecht |
Pharmaceutical and diagnostic use of Serum Amyloid P component
|
|
CN1307590A
(zh)
|
1998-02-17 |
2001-08-08 |
米德列斯公司 |
用fc受体配基治疗和诊断巨噬细胞介导的疾病
|
|
ES2220257T1
(es)
|
1998-03-11 |
2004-12-16 |
Kabushiki Kaisha Soken |
Agentes normalizadores para la piel.
|
|
JPH11319542A
(ja)
|
1998-05-08 |
1999-11-24 |
Tokuyama Corp |
超薄層の製造方法
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US6600019B2
(en)
|
2000-01-06 |
2003-07-29 |
Curagen Corporation |
Polypeptides and nucleic acids encoding same
|
|
EP1267795A1
(en)
|
2000-03-30 |
2003-01-02 |
Brennen Medical Inc. |
Anti-microbial and immunostimulating composition
|
|
US20040068095A1
(en)
|
2001-03-14 |
2004-04-08 |
Shimkets Richard A. |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
|
US7713705B2
(en)
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
|
US6872541B2
(en)
|
2001-07-25 |
2005-03-29 |
Coulter International Corp. |
Method and compositions for analysis of pentraxin receptors as indicators of disease
|
|
US6537811B1
(en)
|
2001-08-01 |
2003-03-25 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of SAP-1 expression
|
|
US20030199442A1
(en)
|
2001-10-09 |
2003-10-23 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US7022476B2
(en)
|
2002-02-26 |
2006-04-04 |
New York Society For Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof
|
|
GB0211136D0
(en)
|
2002-05-15 |
2002-06-26 |
Univ London |
Treatment and prevention of tissue damage
|
|
BR0310084A
(pt)
|
2002-05-17 |
2005-02-15 |
Novartis Ag |
Composição farmacêutica compreendendo um inibidor de renina, um bloqueador de canal de cálcio e um diurético
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
WO2004016750A2
(en)
|
2002-08-14 |
2004-02-26 |
Macrogenics, Inc. |
FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
|
|
US8946387B2
(en)
|
2002-08-14 |
2015-02-03 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
JP4819364B2
(ja)
|
2002-12-23 |
2011-11-24 |
ウイリアム、マーシュ、ライス、ユーニヴァーサティ |
線維細胞形成阻害の検出方法、ならびに線維細胞形成を増強する方法および化合物
|
|
US8012472B2
(en)
|
2002-12-23 |
2011-09-06 |
William Marsh Rice University |
Compositions and methods for suppressing fibrocytes
|
|
US7763256B2
(en)
|
2002-12-23 |
2010-07-27 |
William Marsh Rice University |
Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
|
|
US20070149450A1
(en)
|
2003-02-27 |
2007-06-28 |
Ranjit Bhardwaj |
Method for reducing levels of c-reactive protein
|
|
SG173322A1
(en)
|
2004-04-16 |
2011-08-29 |
Macrogenics Inc Dw Us |
Fc gammad riib - specific antibodies and methods of use thereof
|
|
JP2007536932A
(ja)
|
2004-05-10 |
2007-12-20 |
マクロジェニクス，インコーポレーテッド |
ヒト化ＦｃγＲＩＩＢ特異的抗体とその利用法
|
|
WO2006002438A2
(en)
|
2004-06-03 |
2006-01-05 |
Medarex, Inc. |
Human monoclonal antibodies to fc gamma receptor i (cd64)
|
|
WO2006002930A2
(en)
|
2004-06-30 |
2006-01-12 |
Friedrich-Alexander- Universitaet Erlangen- Nuernberg |
FcϜRIIa POLYMORPHISM AND ITS USE IN DIAGNOSIS
|
|
ZA200701783B
(en)
|
2004-09-02 |
2009-10-28 |
Genentech Inc |
Anti-Fc-gamma RIIB receptor antibody and uses therefor
|
|
WO2006034373A2
(en)
*
|
2004-09-17 |
2006-03-30 |
Biomarin Pharmaceutical Inc. |
Variants and chemically-modified variants of phenylalanine ammonia-lyase
|
|
US7405302B2
(en)
|
2005-10-11 |
2008-07-29 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
US20070099251A1
(en)
|
2005-10-17 |
2007-05-03 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
AU2007281876B2
(en)
|
2006-06-26 |
2013-09-05 |
Macrogenics, Inc. |
FcgammaRIIB-specific antibodies and methods of use thereof
|
|
US8247370B2
(en)
|
2006-12-04 |
2012-08-21 |
Promedior, Inc. |
Conjoint therapy for treating fibrotic diseases
|
|
ES2554167T3
(es)
*
|
2007-07-06 |
2015-12-16 |
Promedior Inc. |
Métodos y composiciones útiles en el tratamiento de mucositis
|
|
US9884899B2
(en)
*
|
2007-07-06 |
2018-02-06 |
Promedior, Inc. |
Methods for treating fibrosis using CRP antagonists
|
|
US8497243B2
(en)
|
2007-07-06 |
2013-07-30 |
Promedior, Inc. |
Methods and compositions useful in the treatment of mucositis
|
|
US10702583B2
(en)
|
2009-03-11 |
2020-07-07 |
Promedior, Inc. |
Treatment methods for autoimmune disorders
|
|
JP5797565B2
(ja)
|
2009-03-11 |
2015-10-21 |
プロメディオール， インコーポレイテッド |
過敏性障害（ｈｙｐｅｒｓｅｎｓｉｔｉｖｅ ｄｉｓｏｒｄｅｒ）に対する処置および診断方法
|
|
US20100266643A1
(en)
|
2009-04-01 |
2010-10-21 |
Willett W Scott |
Pulmonary and nasal delivery of serum amyloid p
|
|
UA110323C2
(en)
*
|
2009-06-04 |
2015-12-25 |
Promedior Inc |
Derivative of serum amyloid p and their receipt and application
|
|
US8329659B2
(en)
*
|
2009-06-17 |
2012-12-11 |
Promedior, Inc. |
SAP variants and their use
|